PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)
$131.42 -6.22 (-4.519%)
Analysed PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) News Sources
Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800%
30-05-2026
fool.com
Protagonist Therapeutics to Present Phase 3 VERIFY and Long-Term Rusfertide Data at the 2026 European Hematology Association Congress
01-06-2026
yahoo.com
Protagonist Therapeutics Reports Granting of Inducement Awards
01-07-2026
yahoo.com
Why Wall Street’s Wrong for Loving Protagonist Therapeutics Stock
02-07-2026
barchart.com
Strength Seen in Agios Pharmaceuticals (AGIO): Can Its 17.7% Jump Turn into More Strength?
08-07-2026
yahoo.com
Protagonist Therapeutics (PTGX) Surges 7.1%: Is This an Indication of Further Gains?
08-07-2026
yahoo.com
Protagonist Therapeutics (PTGX) Is Up 12.5% After Rusfertide Priority Review Focus - Has The Bull Case Changed?
08-07-2026
yahoo.com
New Strong Buy Stocks for July 9th
09-07-2026
yahoo.com
Protagonist Therapeutics (PTGX) After Icotyde Launch And Rusfertide Review Looks Undervalued
09-07-2026
yahoo.com
Protagonist Therapeutics (PTGX) Stock Still Looks Stretched After FDA Priority Review
09-07-2026
yahoo.com
What is the current price of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)?
The current price of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) is $131.42.
PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) since the previous trading day is $-6.22.
PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) since the previous trading day is -4.519%.
What is the most recent average sentiment score for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)?
The most recent average sentiment score for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) is 64 out of 100.
What is the most recent average sentiment for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)?
The most recent sentiment for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) is .
SEC-8K** Filing Available For PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.